Bone Index Ltd., a Finnish firm, landed FDA clearance for its Bindex device that’s used to diagnose osteoporosis. The ultrasound device evaluates the cortical bone thickness of the tibia and provides a measurement of the Density Index that is normally derived from dual-energy x-ray absorptiometry (DXA) bone densitometry systems.
It plugs directly into a laptop running Bindex software and exams can be performed at the point-of-care.
In clinical trials, the system detected osteoporosis with 90% sensitivity and specificity without exposing patients to ionizing radiation.
Bone Index Ltd. claims that its device provides results comparable to DXA, which should point to the technology becoming quite popular over bulky and expensive DXA machines. Moreover, since there is no involvement of radiation, there’s no need for a physician referral to take the test.
Product page: Bindex…
Via: Bone Index Ltd…